These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11176579)

  • 1. Aseptic meningitis in a child after systemic treatment with high dose cytarabine.
    Pease CL; Horton TM; McClain KL; Kaplan SL
    Pediatr Infect Dis J; 2001 Jan; 20(1):87-9. PubMed ID: 11176579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytarabine-induced aseptic meningitis.
    van den Berg H; van der Flier M; van de Wetering MD
    Leukemia; 2001 Apr; 15(4):697-9. PubMed ID: 11368387
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced aseptic meningitis in a Ph+ ALL patient with meningeal involvement.
    Beaumont AL; Suner L
    Blood; 2020 Jul; 136(4):520. PubMed ID: 32702128
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of C-reaction protein for differential diagnosis of fever after chemotherapy on children with acute lymphoblastic leukemia].
    Fang CQ; Tang YM; Li HF; Song H; Shi SW; Yang SL; Xu WQ
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):536-7. PubMed ID: 15324576
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholelithiasis and choledocholithiasis after sequential cytarabine and asparaginase.
    Sandoval C; Katz B; Stringel G; Jayabose S; Lebovics E
    J Pediatr Hematol Oncol; 2003 Aug; 25(8):637-9. PubMed ID: 12902918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia.
    Feldman EJ
    Leuk Res; 2000 Mar; 24(3):189-91. PubMed ID: 10739000
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute basal ganglia necrosis associated with cytarabine therapy.
    Sirvent N; Monpoux F; Benet L; Richelme C; Mariani R; Diaine B
    Med Pediatr Oncol; 1998 May; 30(5):308. PubMed ID: 9544229
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.
    Banklau C; Jindadamrongwech S; Sawangpanich R; Apibal S; Hongeng S; Paisooksantivatana K; Pakakasama S
    Hematol Oncol Stem Cell Ther; 2010; 3(3):103-8. PubMed ID: 20890066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse cerebral vasospasm with infarct after intrathecal cytarabine in childhood leukemia.
    Yoon JH; Yoon JY; Park HJ; Son MH; Kim SH; Kim W; Kim HJ; Lee SH; Park BK
    Pediatr Int; 2014 Dec; 56(6):921-924. PubMed ID: 25521979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high-dose cytarabine in induction therapy for adult ALL.
    Gökbuget N; Hoelzer D
    Leuk Res; 2002 May; 26(5):473-6. PubMed ID: 11916521
    [No Abstract]   [Full Text] [Related]  

  • 11. Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia.
    Aytaç S; Gümrük F; Cetin M; Tuncer M; Yetgin S
    Turk J Pediatr; 2010; 52(2):211-4. PubMed ID: 20560263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of cytarabine syndrome successfully resolved by desensitization.
    Lim KH; Kim JY; Kang MG; Park HK; Kang HR
    J Investig Allergol Clin Immunol; 2015; 25(1):80-2. PubMed ID: 25898709
    [No Abstract]   [Full Text] [Related]  

  • 13. "Reaction to cytarabine (Ara-C) treatment in patients with concurrent Staphylococcus aureus infection: a coalition between Ara-C and superantigens?".
    Savaşan S; Warrier I; Can E; Can M; Gedikoğlu G
    Med Pediatr Oncol; 1998 Apr; 30(4):263-4. PubMed ID: 9473764
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside.
    Ozkan A; Apak H; Celkan T; Yüksel L; Yildiz I
    Pediatr Dermatol; 2001; 18(1):38-40. PubMed ID: 11207969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.
    Yegin ZA; Aki S; Sucak G; Yagci M
    Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy.
    Thordarson H; Talstad I
    Acta Med Scand; 1986; 220(5):493-5. PubMed ID: 3468760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corneal toxicity of cytarabine. Apropos of a case].
    Bursztyn J; Boccara JF; Paillassou B; Bavoux F
    Ophtalmologie; 1989; 3(3):229-30. PubMed ID: 2641118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
    Parasole R; Petruzziello F; Messina C; Barisone E; Pession A; Locatelli F; Micalizzi C; Cesaro S; Testi AM; De Matteo A; Varotto S; Berger M; Morello W; Menna G; Poggi V
    Leuk Lymphoma; 2015 Mar; 56(3):650-5. PubMed ID: 24882262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines.
    Battistini E; Dini G; Savioli C; Morando A; Gandolfo A; Kotitsa Z; Garaventa A; Rossi GA
    Eur Respir J; 1997 May; 10(5):1187-90. PubMed ID: 9163667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin toxicity associated with bolus infusion of low-dose cytarabine].
    Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
    Rinsho Ketsueki; 2001 Mar; 42(3):216-7. PubMed ID: 11345785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.